New Research Debunks "Job-Hopping" Myth About Millennials and Gen Z
National Institute on Retirement Security Research Finds Younger Workers Are Staying in Jobs at Rates Similar to Baby Boomers and Gen X at the Same Age
The new issue brief, Debunking the Job-Hopping Myth: A Data-Driven Look at Tenure and Turnover Among Younger Workers, uses decades of U.S. Bureau of Labor Statistics data and additional independent research to examine employee tenure across generations. Read the research.
"These findings should put to rest the myth that Millennials and Gen Z inherently are job hoppers," said
The research key findings include:
- Median job tenure is nearly identical across generations. Workers aged 25–34 in 2024 (Millennials and Gen Z) had a median tenure of 2.7 years, only slightly lower than Baby Boomers at the same age in 1983.
- Economic conditions, rather than generational attitudes, drive worker turnover. Quit rates rise during strong economies and fall during recessions, as seen during the 2008 Great Recession and the 2020 pandemic.
- Public sector benefits promote retention. State and local government employees have significantly lower quit rates due to more widespread access to pensions and healthcare benefits.
- Industry differences shape job stability. Manufacturing jobs, which traditionally offer stronger benefits, show higher retention rates compared to retail and professional services.
The National Institute on Retirement Security is a non-profit, non-partisan organization established to contribute to informed policymaking by fostering a deep understanding of the value of retirement security to employees, employers and the economy as a whole. Located in
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-research-debunks-job-hopping-myth-about-millennials-and-gen-z-302545191.html
SOURCE National Institute on Retirement Security
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vision Films Announces Release of Documentary "UFOs and GOD"
- Vidle Launches Revolutionary New All-in-One App for Healthcare Travelers
- FibroBiologics Releases Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share